AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06354400 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization training
Description: Isometric exercises of the abdominal muscles in the supine, prone, and squatting positions; isotonic exercises in the supine, prone, squatting, and side-lying positions; isotonic exercises in coordination with the extremity movements in the supine, prone, and crawling positions; and trunk rotation exercises in the sitting position will be performed. The Swiss ball will be used for dynamic exercises. It will include isometric and isotonic exercises of the abdominal muscles. Exercises will start with 3 sets of 20 repetitions, gradually increase in intensity on static and dynamic surfaces, and progress towards difficulty. Each exercise will be performed in coordination with breathing control. Breathing control will be coordinated with every exercise.
Study NCT06436209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multitask Practice Intervention (MPI)
Description: Multitask practice intervention (MPI) includes multiple behavioral testing sessions during which participants receive practice with multitasking two tasks using the psychological refractory period procedure.
Study NCT06436209 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Single-task Practice Intervention (SPI)
Description: Single task practice intervention (SPI) includes multiple behavioral testing sessions during which participants receive separate practice on two tasks.
Study NCT05373082 — intervention group
Intervention type: OTHER
Intervention: questionnaire completion
Description: Questionnaire to be completed by patients
Study NCT05877352 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intraoperative Electron Radiotherapy (IOERT)
Description: IOERT can be defined as the direct application of high-energy electron beam irradiation to a tumour bed during an operative procedure. This approach permits precise delivery of a single large fraction of radiation directly and specifically to high recurrence risk anatomical target areas, which the treating clinicians (surgeon and attending clinical oncologist) predict will be a close or involved margin, while simultaneously displacing and shielding dose-limiting radiosensitive structures such as the small bowel or ureter or any anastomoses, if not involved by tumour.
Study NCT05877352 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Extended Margin Surgery
Description: Surgery intended to remove both a tumour and any metastases
Study NCT05877352 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Extended Margin Surgery
Description: Surgery intended to remove both a tumour and any metastases
Study NCT05775874 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: AZD4547
Description: Initiation dose: 80mg BID,po.
Study NCT05775874 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tislelizumab
Description: Tislelizumab:200mg Q3W
Study NCT04996160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Oral
Study NCT04901988 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab 10 MG/ML
Description: Eligible patients randomised to Arm B will receive 480 mg nivolumab monotherapy 4 weekly via IV infusion for up to 2 years.
Study NCT03988283 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Personalized neoantigen DNA vaccine
Description: At each vaccination time point, patients will receive one injection of the neoantigen DNA vaccine, one injection into the vastus lateralis.
Study NCT03988283 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Papivax Biotech TDS-IM v2.0
Description: All study injections will be given intramuscularly using an integrated electroporation device (TDS-IM v2.0 device - Papivax Biotech).
Study NCT03988283 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peripheral blood draw
Description: -After trial enrollment and up to 7 days after the first vaccine dose (baseline); no more than 2 weeks after the 3rd vaccine dose; no more than 2 weeks after the 6th vaccine dose; two weeks after the last dose; time of progression or discontinuation (optional)
Study NCT06633237 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core training program in female amateur basketball players
Description: The intervention consists of a core training program specifically designed to improve core and trunk stability in female amateur basketball players. The program is integrated into the warm-up routine and is applied twice a week over an 8-week period. Each session lasts approximately 12-15 minutes and includes five exercises. The training program is divided into three phases of progression, gradually increasing the difficulty of the exercises over the 8 weeks by incorporating more dynamic and functional movements.
Study NCT06427837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Same 2nd course
Description: The same snack food will be served in the second course
Study NCT06427837 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Different 2nd course
Description: A different snack food will be served in the second course
Study NCT06406218 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Phase I Cardiac Rehabilitation Exercise Training
Description: A) In the morning, take a supine position and perform straight leg raises with each leg individually, lifting to a height of 30° and holding for 3-5 seconds. Raise both arms to the side of the head to a 90° angle and hold for 5-10 seconds. Inhale deeply when exerting force and exhale slowly when lowering. Alternate between leg lifts and arm raises, performing 5 sets per session. Adjust intensity based on individual condition and may be repeated. In the afternoon, sit beside the bed for 5 minutes. B) After transitioning to secondary care according to the patient's condition, stand beside the bed for 5 minutes in the morning; in the afternoon, march in place beside the bed for 5 minutes. C) Walk beside the bed for 10 minutes per session, twice a day. D) Move around and doing activities under supervision inside the ward, 10 minutes per session, twice a day.~Spend approximately one day at each level, gradually progressing the exercise to the patient's tolerance level.
Study NCT05149677 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: Music therapy intervention + Standard of Care for labor pain
Study NCT05990153 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release (MR)
Description: Myofascial release therapy is a type of gentle, constant massage that releases tightness and pain throughout myofascial tissues.
Study NCT05228132 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pristine™ Long-Term Hemodialysis Catheter
Description: Placement of the Pristine™ Long-Term Hemodialysis Catheter Placement.
Study NCT05948527 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high flow nasal canula
Description: administration of high flow nasal canula at initial flow 35 liters per minute and Fio2 (fraction of inspired oxygen of 50%) with titration to reach oxygen saturation of 88-92%.
Study NCT01297946 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Conventional continuous subcutaneous insulin infusion therapy
Study NCT01297946 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dual-hormone closed-loop
Study NCT06349265 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carpal Tunnel Hydrodissection with %5 dextrose in water injection
Description: Under the inplane ulnar approach, 3ml injectate was injected to hydrodissect the median nerve from the flexor retinaculum, and the residual 2ml injectate was then injected to hydrodissect the inferior median nerve away from the flexor tendons.
Study NCT05720052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MS-553
Description: MS-553 oral tablet BID x 28-days
Study NCT06395896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breast Cancer Prevention Journey Program Group
Description: The researcher will invite individuals to the study at Necip Fazıl Family Center and conduct a pre-test application. The day and time for the Fight Against Breast Cancer training, which is structured based on the Health Belief Model prepared by the researchers, will be determined and announced to the participants. The training will be held in a single session of 45-60 minutes. Slide presentation and a breast model showing the symptoms of breast cancer will be used as training materials. At the end of the training, it will be announced that free shuttle service will be provided for mammography screening and individuals will be invited to screening. On the specified day and time, participants will be taken to the Cancer Early Diagnosis, Screening and Education Center (KETEM) in Mamak and mammography screening will be performed. After the screening, a post-test will be performed.
Study NCT06395896 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine Cancer Screening Program Group
Description: Participants in the control group will not receive any additional intervention. This group will only receive routine intervention within the scope of the breast cancer screening program conducted by the Ministry of Health. Health Ministry of Türkiye offers free mammography screening for breast cancer to women over the age of 40. In this context, women are called to the centers by phone and mammography screening is performed free of charge.
Study NCT03932318 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lintuzumab-Ac225
Description: In the Phase I, patients will be enrolled into the following dose escalation cohorts: 0.50 μCi/kg, 1.0 μCi/kg, and 1.5 μCi/kg. If the 0.50 μCi/kg dose is determined to exceed the MTD, a 0.25 μCi/kg dose will be explored.
Study NCT03932318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: 400 mg daily will be taken orally on Days 1-21 of a 28-day cycle. There will be a ramp up of venetoclax dosing in the first cycle, with 100 mg administered on Day 1, 200 mg on Day 2, and 400 mg on Day 3 and Day 4 and later. Patients on antifungal azoles should receive one-half these doses, up to a maximum of 200 mg of venetoclax.
Study NCT03932318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: 75 mg/m2 will be administered on days 1-7 of a 28-day cycle.
Study NCT05223569 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home OCT monitoring model
Description: A home monitoring set, which includes a self-administrated OCT, and a self-administrated smartphone-based visual acuity tester
Study NCT05223569 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hospital-based monitoring with a staff-administrated OCT
Description: Participants come back to the clinic to receive traditional OCT and VA examinations operated by the study coordinators
Study NCT05619094 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Corrective exercise program
Description: Strengthening exercises for deep cervical flexor muscles and shoulder retractors.~Stretching exercises for cervical extensors and pectoral muscles.
Study NCT06398093 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Compassion Tool Kit
Description: Participants will mediate, journal their reactions, exercise, and apply sleep hygiene measures over the course of four weeks.
Study NCT06136455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Listerine Clinical Solutions Teeth Strength
Description: After brushing for 1 timed minute, participants will rinse full strength for 1 minute with Listerine Clinical Solutions Teeth Strength mouthwash.
Study NCT04996160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 8 mg/m2/day divided BID, PO, NG, or IV
Study NCT02388477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxycycline
Description: antibiotic used to treat infection
Study NCT02388477 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sugar pill
Description: placebo with no pharmacologic effect
Study NCT04870463 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Maxillary and mandibular Cone Beam Computed Tomography record
Description: A Cone Beam Computed Tomography image of each patient of each group at three different moments of the study (baseline/T0, 8-9 months of treatment/T1 and end of treatment/T2)
Study NCT04870463 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Maxillary and mandibular Cone Beam Computed Tomography record
Description: A Cone Beam Computed Tomography image of each patient of each group at three different moments of the study (baseline/T0, 8-9 months of treatment/T1 and end of treatment/T2)
Study NCT05466136 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mental fatigue condition
Description: In mental fatigue condition, the mental fatigue manipulation will use a modified Stroop task with complete incongruent trials, which is wildly used to induce a mentally fatigued state in previous studies. The Stroop task included four colored words presented in traditional Chinese (i.e., red, green, blue, and yellow), the color of the word will paint inconsistent with the semantic meaning of the word (e.g., red word printed in green). The task consisted of five 6-minute blocks and 1080 incongruent trials for each block. The total duration will be 30-min.
Study NCT05466136 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control condition
Description: Similar to mental fatigue conditions, the modified Stroop task with complete congruent trials will be used, The Stroop task also included four colored words presented in traditional Chinese (i.e., red, green, blue, and yellow), but the color of the word will paint consistent with the semantic meaning of the word (e.g., red word printed in red) in order to set up the match condition of relative less cognitive demanding for participants. Same with the mental fatigue condition, the task consisted of five 6-minute blocks and 1080 congruent trials for each block. The total duration will be 30-min.
Study NCT04637776 — intervention group
Intervention type: OTHER
Intervention: Hospitalization
Description: Hospitalization for any reason
Study NCT04662190 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D printing model/guide.
Description: Orbital decompression surgery will be previously planned and simulated using 3D-printed individualized models. In the operating room, surgery will be assisted with 3D-printed individualized guides.
Study NCT04662190 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard surgery
Description: Orbital decompression surgery will be previously planned and simulated using the actual standard methods.
Study NCT05561439 — intervention group
Intervention type: OTHER
Intervention: Dosimetric monitoring
Description: Dosimetric monitoring of workers Information retrieved from passive dosimeters results from the years 2019, 2020 and 2021
Study NCT06136455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Listerine Total Care Zero Alcohol Mouthwash
Description: After brushing for 1 timed minute, participants will rinse full strength for 1 minute with Listerine Total Care Zero mouthwash.
Study NCT06136455 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Listerine Cool Mint Zero Alcohol Mouthwash
Description: After brushing for 1 timed minute, participants will rinse full strength for 30 seconds with Listerine Cool Mint Zero mouthwash.
Study NCT06136455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colgate Cavity Protection Toothpaste
Description: Participants will brush for 1 timed minute with Colgate Cavity Protection toothpaste.
Study NCT06136455 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Colgate Cavity Protection Toothpaste
Description: Participants will brush for 1 timed minute with Colgate Cavity Protection toothpaste.
Study NCT04985864 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Brain stimulation
Description: tDCS brain stimulation on leg motor areas was applied to stroke patients.
Study NCT04985864 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Treadmill gait training
Description: Lokomat robot training was applied to stroke patients.
Study NCT04985864 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treadmill gait training
Description: Lokomat robot training was applied to stroke patients.
Study NCT06440096 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: hemogram
Description: hemogram
Study NCT04996160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: 1.3 mg/m2/dose, IV (preferred) or SC
Study NCT05392049 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bowen's therapy
Description: Bowens technique will be apply on patients of TMJ for 2 repetitions in 1 set, 4 sets in each session for 4 weeks.
Study NCT05392049 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post isometric relaxation
Description: post isometric relaxation technique and jaw exercises (strengthen the weakened muscles, stretch the shortened muscles) with dosage 5 times/session, 5 sec rest and 2times/week for 4 weeks will apply on patients.
Study NCT05793684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Period A
Description: Week 1: Viloxazine low dose + placebo; Week 2: Viloxazine high dose + placebo
Study NCT05793684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Period B
Description: Week 1: AD816 low dose; Week 2: AD816 high dose
Study NCT04922372 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: peek
Description: After tooth preparation, adequate 2ry Impression using non aqueous elastomeric impression materials and bite registration will be taken. 5. Fabrication of the temporary restoration using composite resin temporary material and cemented using non Eugenol Zinc Oxide temporary cement. 11.a.iii. Fabrication and cementation of restoration: Bio-HPP will be supplied in the form of discs to fabricate crown core by CAD/CAM technology then veneered with two veneering techniques; the CAD/ CAM and the manual technique using the visio.lign system of appropriate shade. The finished Bio HPP crown will be cemented by adhesive resin cement according to manufacturer instruction
Study NCT04922372 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: peek
Description: After tooth preparation, adequate 2ry Impression using non aqueous elastomeric impression materials and bite registration will be taken. 5. Fabrication of the temporary restoration using composite resin temporary material and cemented using non Eugenol Zinc Oxide temporary cement. 11.a.iii. Fabrication and cementation of restoration: Bio-HPP will be supplied in the form of discs to fabricate crown core by CAD/CAM technology then veneered with two veneering techniques; the CAD/ CAM and the manual technique using the visio.lign system of appropriate shade. The finished Bio HPP crown will be cemented by adhesive resin cement according to manufacturer instruction
Study NCT05372978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cash transfer
Description: Participants will receive a one-time unconditional cash transfer of $8,500.
Study NCT05745337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
Description: Patients will stop their daily beta-blocker and take as-needed rate control (beta-blocker or calcium channel blocker) guided by their implantable cardiac monitor
Study NCT05123339 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire
Study NCT06099223 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture needles
Description: The acupuncture intervention includes a combination of auricular and body acupuncture. The auricular points used are Shen men, Zero point, Tranquilizer point, and Master cerebral.~The body points used are the wrist PC6.
Study NCT04162639 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Skin allograft
Description: Participants will receive skin allograft from either 1, 2 or 3 distinct cadavers. This skin allograft will be applied in a routine fashion, with no deviation from the typical clinical course of treatment.
Study NCT04996160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: 25 mg/m2/dose IV
Study NCT04893317 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ablation in the ventricles with the Adagio Medical VT Cryoablation System
Description: The Adagio Medical VT Cryoablation System is indicated for the treatment of monomorphic ventricular tachycardia by ablation of arrhythmogenic tissue that drives and maintains these arrhythmias
Study NCT06658938 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Blinatumomab
Description: Beginning 3 months after transplantation, 1 cycle of blinatumomab was performed every 3 months for a total of 4 maintenance cycles.~Dosage of blinatumomab: 9 ug/d D1-4, 28 ug/d D5-14
Study NCT05509790 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3484356
Description: Administered orally.
Study NCT05027347 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: plasma circulating tumor DNA
Description: A liquid biopsy assay for identification of tumor derived mutations in plasma of gastric cancer
Study NCT06093308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deuremidevir Hydrobromide Tablets
Description: Multiple administration, oral administration after meals, D1: 0.6g, twice a day; D2-D5: 0.3g, twice a day; D6: 0.3g, administered once in the morning
Study NCT05262777 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GP0112
Description: Injectable gel
Study NCT05262777 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Restylane Lyft Lidocaine
Description: Injectable gel